LGALS3 and breast cancer: Advanced locoregional invasion and decreased overall survival of patients with breast cancer correlates with lower expression levels of Gal-3, and Gal-3 silencing in breast cancer cell lines reduces Wnt and Akt signaling, decreases anoikis, promotes EMT, enhances drug resistance and stimulates their tumor growth in mice [151].